Keywords: still, fda, verdict, lundbeck, serdolect, denmark, says

Still no FDA verdict for H Lundbeck's Serdolect

Article | 21 May 2009

Print This

Denmark's H Lundbeck says it has not yet received a US approval decision for Serdolect (sertindole) in schizophrenia. The firm ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in